General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Alnylam(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Alexion(MODEST), AstraZeneca Pharmaceuticals(MODEST), Pfizer Inc(SIGNIFICANT), Eidos(SIGNIFICANT), Janssen Pharmaceuticals, Inc(MODEST), Ionis(MODEST)

View Full Disclosure